Glioblastoma Remote Monitoring and Care - Research Protocol

Description

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.

Conditions

Glioblastoma, Venous Thromboembolism, Seizures

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.

Glioblastoma Remote Monitoring and Care - Research Protocol

Glioblastoma Remote Monitoring and Care - Research Protocol

Condition
Glioblastoma
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * newly-diagnosed or recurrent glioblastoma undergoing treatment or active surveillance
  • * at least 18 years of age at the time of study enrolment
  • * Karnofsky Performance Status (KPS) ≥ 70% at time of study enrolment
  • * able to comprehend informed consent form and provide informed consent
  • * access to patient or caregiver's own Apple iPhone to interface with watch application for documentation of symptoms
  • * under 18 years of age at the time of study enrolment
  • * inability to give informed consent due to aphasia or other language barrier
  • * tattoos located on the skin of the wrist or forearm where the Apple Watch will be placed or other skin conditions preventing adequate sensor function
  • * inability to tolerate Apple Watch for at least 12 hours per day on at least 50% of days in a four-week period
  • * no access to patient or caregiver Apple iPhone to document symptoms

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Case Comprehensive Cancer Center,

Andrew Dhawan, MD, DPhil, PRINCIPAL_INVESTIGATOR, Brain Tumor Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Rowan Barker-Clarke, PhD, PRINCIPAL_INVESTIGATOR, Lerner Research Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Siamrut Patanavanich, PRINCIPAL_INVESTIGATOR, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Study Record Dates

2027-01-01